To obtain access to any datasets listed on this site, you must first receive approval from NIDA Datashare's Data Access Committee (DAC).

Please submit your request by sending your request to NIDA_Datashare_DAC@nih.gov along with the following information:

  • Your name, title, and organization
  • Study Number and Study Title
  • The specific dataset(s) you are requesting
  • The intended use or purpose of the data
  • Willingness to comply with the NIDA Datashare Registration Agreement
Once your request is reviewed, you will receive instructions on how to proceed.

Thank you for your cooperation.

NIDA-CTN-0030A3

Division
CTN
HEAL Study
No
Investigator(s)
Roger Weiss, M.D.
Jennifer Sharpe Potter, Ph.D.
Title
Long-Term Follow-Up to CTN-0030 (A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic Dependence)
Short Description
An ancillary study to CTN-0030 to examine long-term outcomes for individuals with opioid analgesic dependence.
Release Date
Aug 22, 2014
Description

This was an ancillary study to CTN-0030, a two-phase randomized controlled clinical trial of buprenorphine/naloxone treatment plus individual drug counseling for opioid analgesic dependence. All participants (648) randomized to Phase 1 of the CTN-0030 study were eligible for the ancillary study. Participants were assessed via telephone at 1.5, 2.5, and 3.5 years post-Phase 1 randomization into the CTN-0030 study. The study evaluated opioid use, quality of life, and pain.

Keywords
buprenorphine
naloxone
opiate
Assessments
Addiction Severity Index Lite
Composite International Diagnostic Interview for DSM-IV
Fagerstrom Test for Nicotine Dependence
Pain and Opioid Analgesics Use History
SF-36 and SF-12 Health Status Questionnaire
Accessibility Notice

Please note that the supplementary documents may not be fully Section 508 compliant. Please contact us for assistance.

Study Links
Primary Manuscript
CTN-0030a3 Primary Manuscript